MNBTD
PTCT icon

Moody National Bank Trust Division’s PTC Therapeutics PTCT Stock Holding History

Moody National Bank Trust Division’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-174
Closed -$7K – 819
2019
Q1 		$7K Buy
+174
New +$5.84K ﹤0.01% 730

Other funds holding PTCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Moody National Bank Trust Division's PTCT Position: Q2 2019 in Review

Moody National Bank Trust Division sold out of PTC Therapeutics (PTCT) in Q2 2019, closing a stake of 174 shares — an estimated $7K sold.

Moody National Bank Trust Division first reported a position in PTCT in Q1 2019 and held it in 1 quarter. The position peaked at $7K in Q1 2019. 176 funds tracked by Wall St. Rank hold PTCT as of Q2 2019.

  • Moody National Bank Trust Division reported no remaining PTC Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Moody National Bank Trust Division sold 174 PTC Therapeutics shares in Q2 2019, an estimated $7K.
  • Moody National Bank Trust Division first reported a position in PTC Therapeutics in Q1 2019 and held it in 1 quarter.
  • Moody National Bank Trust Division's PTC Therapeutics position peaked at $7K in Q1 2019.
  • 176 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2019.

Based on Moody National Bank Trust Division's 13F filing for Q2 2019, filed 22 Jul 2019.